Next-generation surveillance strategies for patients with lymphoma. (July 2015)

• Record Type: Journal Article
• Authors: Cohen, Jonathon B; Kurtz, David M; Staton, Ashley D; Flowers, Christopher R
• Is Part Of: Future oncology. Volume 11:Number 13(2015)
• Page Start: 1977
• Page End: 1991
• Publication Date: 2015-07
• Subjects: computed tomography -- Hodgkin lymphoma -- lymphoma -- minimal residual disease -- non-Hodgkin lymphoma -- PET -- surveillance; Oncology -- Periodicals; 616.99405
• DOI: 10.2217/fon.15.92
• Languages: English
• ISSNs: 1479-6694

Abstract

ABSTRACT : While remission and cure rates for Hodgkin and non-Hodgkin lymphoma continue to improve, surveillance approaches remain controversial, especially in light of recent reports suggesting limited benefit for routine radiologic assessment. Routine cross-sectional imaging results in considerable patient expense and anxiety, and this approach does not clearly improve patient outcomes. Next-generation approaches including minimal residual disease detection may provide an opportunity to identify relapse early and intervene prior to progression of clinical disease. This review discusses the role of surveillance imaging in Hodgkin and non-Hodgkin lymphoma and provides an introduction to serologic assessment of minimal residual disease. Future studies will need to focus on the clinical application of minimal residual disease surveillance and its ability to predict relapse, treatment response and survival.